We are proud to announce the launch of OracleBio’s GCP Image Analysis Services. This latest service offering strengthens the company’s position as a global leader in quantitative digital pathology, expanding the company’s foothold in the clinical market.
Our new service offering generates quantitative image analysis data using a workflow that is conducted in accordance with GCP principles. This provides clients with quality assured data which can be included in a data package for submission to regulatory authorities.
OracleBio’s GCP services combine image analysis and pathology expertise in a regulated working environment to provide quality assured data. Regulated activities are supported by a dedicated GCP team, comprising highly experienced scientific and quality assurance staff.
The GCP implementation has been led by Clinical Operations Manager, Alison Bigley, who has decades of experience working to GxP standards and previously implemented GxP Image Analysis systems. Alison commented:
‘We are excited to be able to provide this dedicated unique service, in keeping with GCP ethical, scientific and practical standards, that now underpins the provision of accurate, credible quantitative image analysis data in support of our Clients regulatory clinical trial studies’.
Benefits of OracleBio's GCP Services
- Regulatory reporting – Providing data that can be included in a data package for submission to regulatory authorities
- Confidence in clinical data – Our GCP services provide quality assured data you can trust
Find out about OracleBio's Pathology Expertise
Meet the OracleBio Leadership Team
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more